www.hivandhepatitis.com

Back HCV Disease Progression

EASL 2017: Hepatitis C Treatment Allows 1 in 4 to Come Off Liver Transplant Waiting List

Details
Category: Liver Cancer/HCC
Published on Monday, 01 May 2017 00:00
Written by Keith Alcorn
  • Print

Around a quarter of people with hepatitis C and decompensated cirrhosis came off liver transplant waiting lists in Europe after direct-acting antiviral (DAA) treatment, and very few had any subsequent liver-related problems during 15 months of follow-up, Luca Belli reported on behalf of the ELITA study investigators at the EASL International Liver Congress last month in Amsterdam.

alt

Read more:

More Articles...

  1. EASL 2017: Direct-Acting Antivirals for Hepatitis C Not Linked to Higher Liver Cancer Risk
  2. CROI 2017: Are HIV/HCV Coinfected People Cured with DAAs at Increased Risk for Liver Cancer?
  3. AASLD 2016: Is DAA Treatment for Hepatitis C Reducing the Need for Liver Transplants?
  4. AASLD 2016: Curing Hepatitis C Reduces Liver-Related Complications and Death
  5. AASLD 2016: Liver Cirrhosis and Decompensation on the Rise Among People with Hepatitis C

Subcategories

Copyright © 2023 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design